
Supplementation with Boswellia serrata extract versus placebo for knee osteoarthritis treatment

Supplementation with Boswellia serrata extract versus placebo for knee osteoarthritis treatment
A pilot, randomized, double-blind, placebo-controlled trial to assess the safety and efficacy of a novel Boswellia serrata extract in the management of osteoarthritis of the knee
Phytother Res. 2019 May;33(5):1457-1468. doi: 10.1002/ptr.6338Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
48 patients with knee osteoarthritis were randomized to daily oral supplementation with either Boswellia serrata extract or placebo. Patients were followed over 4 months of treatment for outcome related to pain and function. After 4 months, results demonstrated significantly greater improvement in the BSE group for the Western Ontario and McMaster Universities Osteoarthritis Index, visual analog p...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!

Learn about our AI Driven
High Impact Search Feature

Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.